Bacteriocin-based solutions for diverse industries

Publication ID: 24-11857606_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Bacteriocin-based solutions for diverse industries,” Published Technical Disclosure No. 24-11857606_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857606_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,606.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of therapeutic bacteriocins to develop novel applications and use cases in various industries, including agriculture, food preservation, bioremediation, biofilm control, and cosmetics.

Background and Problem Solved

The original patent disclosed therapeutic bacteriocins for reducing microbial growth. However, the potential of bacteriocins extends beyond medical applications. The present inventive concept addresses the limitation of the original patent by exploring new industries where bacteriocin-based solutions can provide significant value.

Detailed Description of the Inventive Concept

The inventive concept comprises bacteriocin-based compositions tailored to specific industries. For instance, in agriculture, the bacteriocin targets and kills specific pest species, reducing crop damage and increasing yield. In food preservation, the bacteriocin-based antimicrobial composition prevents spoilage and extends shelf life. Similarly, in bioremediation, the bacteriocin breaks down environmental pollutants, restoring ecological balance. In biofilm control, the bacteriocin prevents biofilm formation, reducing the risk of infection. Lastly, in cosmetics, the bacteriocin targets and reduces acne-causing bacteria, promoting healthy skin.

Novelty and Inventive Step

The new claims introduce novel applications and use cases of bacteriocin-based solutions, which are not obvious from the original patent. The inventive step lies in the adaptation of the core technology to address specific challenges in diverse industries, resulting in innovative solutions with significant commercial potential.

Alternative Embodiments and Variations

Alternative embodiments may include varying the bacteriocin composition, modifying the delivery mechanism, or combining bacteriocins with other agents to enhance their efficacy. Variations may also involve targeting different species or strains within an industry or exploring additional industries where bacteriocin-based solutions can provide value.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across various industries, including agriculture, food preservation, bioremediation, biofilm control, and cosmetics. The target market includes companies, organizations, and governments seeking innovative solutions to address specific challenges in these industries.

CPC Classifications

SectionClassGroup
A A61 A61K38/43
A A01 A01N63/10
A A01 A01N63/50
C C07 C07K14/21
C C07 C07K14/26
C C12 C12N9/2462

Original Patent Information

Patent NumberUS 11,857,606
TitleTherapeutic bacteriocins
Assignee(s)BACTOCLEAR HOLDINGS PTE. LTD.